12 High Growth Large Cap Stocks to Buy Now
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
Dexcom Inc (DXCM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 2,429,523 | $162,875,222 | +6698% | 0.13% |
| 2. | Citadel Investment Group Ken Griffin | 1,233,844 | $82,716,902 | +70% | 0.01% |
| 3. | 92,700,000 | $82,271,250 | +13% | 2.33% | |
| 4. | 1,217,200 | $81,601,088 | +193% | 0.01% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 1,143,476 | $76,658,631 | +183% | 0.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $50.01 | 25,000 | Director | 58,502 | 2017-11-07 | Filing | |
| $49.61 | 10,000 | Director | 33,502 | 2017-11-06 | Filing | |
| $15.50 | 70,000 | Director | 121,975 | 2013-03-11 | Filing | |
| $10.37 | 1,000 | Director | 6,000 | 2012-03-08 | Filing | |
| $10.34 | 1,000 | Director | 5,000 | 2012-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $75.51 | 3,500 | Officer | 80,774 | 2024-11-15 | Filing | |
| $70.00 | 1,000 | Director | 24,349 | 2024-09-16 | Filing | |
| $69.15 | 426 | Officer | 75,451 | 2024-09-09 | Filing | |
| $69.15 | 746 | Officer | 84,274 | 2024-09-09 | Filing | |
| $69.15 | 746 | Officer | 264,915 | 2024-09-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 44,467,463 | $5,517,967,483 | 0.12% | |
| 2. | 32,726,186 | $4,060,992,422 | 0.1% | |
| 3. | 16,520,313 | $2,050,005,640 | 1.69% | |
| 4. | 16,198,598 | $2,010,084,026 | 0.09% | |
| 5. | 15,296,032 | $1,898,085,347 | 0.46% |
News See All
DexCom (DXCM) Fell Due to an Uncharacteristic Earnings Miss
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The U.S.
Here's Why DexCom (DXCM) Detracted in Q3
Investment advisory firm Ithaka Group released the “Ithaka US Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Worst Performing Stocks in S&P 500 in 2024
Since 2023, the market has experienced extended winning streaks, reflecting the economy's resilience.
Multiple Headwinds Dragged DexCom (DXCM) in Q3
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
DexCom, Inc. (NASDAQ:DXCM) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the DexCom Third Quarter 2024 Earnings Release Conference Call. My name is Abby, and I will be your operator for today's call.
Jim Cramer's Latest Stock Picks
On Monday, Jim Cramer of Mad Money took a closer look at the market’s recent movements, reassuring investors that rising bond yields shouldn’t cause excessive worry.
10 Worst Performing NASDAQ Stocks in 2024
Markets have been soaring for the better part of the year, with pullbacks acting as entry levels from where investors have joined and pushed the market higher.
10 Best QQQ Stocks to Buy According to Analysts
Several recent discussions have focused solely on the implications of the Fed's recent rate cut for the market.
10 Best Internet of Things (IoT) Stocks to Buy
The Internet of Things (IoT) is a vast network connecting physical objects to the internet.
Billionaire Hedge Funds
